All Stories

  1. Local control and patient survival after stereotactic radiosurgery for esophageal cancer brain metastases: an international multicenter analysis
  2. Vestibular Schwannoma Koos Grade I International Study of Active Surveillance Versus Stereotactic Radiosurgery: The VISAS-K1 Study
  3. Vestibular Schwannoma Koos Grade II International Study of Active Surveillance Versus Stereotactic Radiosurgery: The VISAS-K2 Study
  4. Comparative analysis of stereotactic radiosurgery outcomes for supratentorial hemangioblastomas in von hippel-lindau disease and sporadic cases: A multi-center international study
  5. Vestibular Schwannoma International Study of Active Surveillance Versus Stereotactic Radiosurgery: The VISAS Study
  6. Stereotactic Radiosurgery With Versus Without Neoadjuvant Endovascular Embolization for Brain Arteriovenous Malformations With Associated Intracranial Aneurysms
  7. The relevance of biologically effective dose for pain relief and sensory dysfunction after Gamma Knife radiosurgery for trigeminal neuralgia: an 871-patient multicenter study
  8. Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up
  9. The AANS/CNS Section on Tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumors
  10. Impact of Multiple Sclerosis Subtypes on Pain Management in Patients With Trigeminal Neuralgia After Stereotactic Radiosurgery: An International Multicenter Analysis
  11. Clinical outcomes following stereotactic radiosurgery for cerebral cavernous malformations of the basal ganglia and thalamus
  12. Local control and survival after stereotactic radiosurgery for colorectal cancer brain metastases: an international multicenter analysis
  13. Stereotactic radiosurgery in the management of non–small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry
  14. Selected-Lesion Stereotactic Radiosurgery (SL-SRS) as a Novel Strategy in the Treatment of Patients With Multiple Brain Metastases
  15. Stereotactic radiosurgery for haemorrhagic cerebral cavernous malformation: a multi-institutional, retrospective study
  16. Clinical and Imaging Outcomes After Trigeminal Schwannoma Radiosurgery: Results From a Multicenter, International Cohort Study
  17. Silent Corticotroph Staining Pituitary Neuroendocrine Tumors: Prognostic Significance in Radiosurgery
  18. Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study
  19. Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis
  20. Treatment of adverse radiation effects with Boswellia serrata after failure of pentoxifylline and vitamin E: illustrative cases
  21. Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study
  22. Adjuvant versus on-progression Gamma Knife radiosurgery for residual nonfunctioning pituitary adenomas: a matched-cohort analysis
  23. Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry
  24. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study
  25. Stereotactic radiosurgery for the treatment of hypoglossal schwannoma: a multi-institutional retrospective study
  26. Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study
  27. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study
  28. Clinical and radiologic outcomes after stereotactic radiosurgery for meningiomas in direct contact with the optic apparatus: an international multicenter study
  29. Stereotactic radiosurgery for clinoid meningiomas: a multi-institutional study
  30. Stereotactic Radiosurgery for Olfactory Groove Meningiomas: An International, Multicenter Study
  31. Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA
  32. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry
  33. Stereotactic Radiosurgery for Perioptic Meningiomas: An International, Multicenter Study
  34. Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results From a Multicenter, International Cohort Study
  35. Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study
  36. Stereotactic radiosurgery with versus without prior Onyx embolization for brain arteriovenous malformations
  37. Stereotactic Radiosurgery With Versus Without Embolization for Brain Arteriovenous Malformations
  38. Embolization of Brain Arteriovenous Malformations With Versus Without Onyx Before Stereotactic Radiosurgery
  39. Earlier radiosurgery leads to better pain relief and less medication usage for trigeminal neuralgia patients: an international multicenter study
  40. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
  41. Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry
  42. Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF)
  43. Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives
  44. Ventricular violation increases the risk of leptomeningeal disease in cavity-directed radiosurgery treated patients
  45. Commentary: Stereotactic Radiosurgery Training for Neurosurgery Residents: Results of a Survey of Residents, Attendings, and Program Directors by the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors
  46. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
  47. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
  48. BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study
  49. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
  50. Oncogenic Signaling Pathways in The Cancer Genome Atlas
  51. A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
  52. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
  53. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
  54. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
  55. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
  56. Genomic and Functional Approaches to Understanding Cancer Aneuploidy
  57. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
  58. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
  59. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
  60. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
  61. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
  62. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
  63. Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery
  64. Medulloblastoma in adults
  65. EXTH-47. DEVELOPMENT OF NANOFIBER-BASED CONTROLLED LOCAL DRUG DELIVERY AS A NOVEL ADJUVANT MODALITY FOR TREATMENT OF GLIOBLASTOMA
  66. A rare case of central nervous system amyloidoma treated with fractionated radiotherapy
  67. Radioactive seed migration in the brain
  68. Debulking Surgery of Pituitary Adenoma as a Strategy to Facilitate Definitive Stereotactic Radiosurgery: A Retrospective Review
  69. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
  70. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
  71. International Differences in Treatment and Clinical Outcomes for High Grade Glioma
  72. CN-13 * RECURRENT ASEPTIC MENINGITIS IN PATIENTS WITH METASTATIC BRAIN TUMORS; A NOVEL PERSPECTIVE
  73. NT-06 * PHOSPHATIDYLSERINE-SELECTIVE TARGETING AND ANTICANCER EFFECTS OF SapC-DOPS NANOVESICLES ON BRAIN TUMORS
  74. Target definition for malignant gliomas: No difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging
  75. Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation
  76. Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
  77. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
  78. Methylation markers of malignant potential in meningiomas
  79. The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis
  80. Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients
  81. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas
  82. Abstract LB-277: Microenvironment-induced changes in miRNA levels promote brain metastasis, drug resistance and KRA expression.
  83. Patient Selection for Anti-Egfviii Therapies in Glioblastoma Multiforme (GBM): Use of Circulating Tumor DNA
  84. Measuring surgical outcomes in neurosurgery: implementation, analysis, and auditing a prospective series of more than 5000 procedures
  85. Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy
  86. Management strategies after nondiagnostic results with frameless stereotactic needle biopsy: Retrospective review of 28 patients
  87. Family History of Cancer in Benign Brain Tumor Subtypes Versus Gliomas
  88. Irradiated Volume as a Predictor of Brain Radionecrosis After Linear Accelerator Stereotactic Radiosurgery
  89. Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases
  90. Evaluation of Image-Guided Positioning for Frameless Intracranial Radiosurgery
  91. Frameless Image-Guided Intracranial Stereotactic Radiosurgery: Clinical Outcomes for Brain Metastases
  92. Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy
  93. Intracranial Treatment for Solitary Prostatic Adenocarcinoma Brain Metastasis is Curative
  94. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme
  95. Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two-institution experience
  96. GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials
  97. Resident training in neurosurgical oncology: results of the survey of North American training programs by the AANS/CNS Section on Tumors
  98. Adaptation of a standard low-field (0.3-T) system to the operating room: focus on pituitary adenomas
  99. Stereotactic Radiosurgery for Patients with Solid Brain Metastases: Current Status
  100. Results of Contemporary Surgical Management of Radiation Necrosis using Frameless Stereotaxis and Intraoperative Magnetic Resonance Imaging
  101. Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma
  102. Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma
  103. Tumor Resection in a Shared-Resource Magnetic Resonance Operating Room: Experience at the University of Cincinnati
  104. Clinical Experience with a Shared-Resource, Intraoperative Magnetic Resonance Imaging Center for Resection of Intracranial Neoplasms
  105. Management Strategy for Adult Patients with Dorsal Midbrain Gliomas
  106. Intraoperative Magnetic Resonance Imaging to Determine the Extent of Resection of Pituitary Macroadenomas during Transsphenoidal Microsurgery
  107. Distant Wounded Glioma Syndrome: Report of Two Cases
  108. Glioma Resection in a Shared-resource Magnetic Resonance Operating Room after Optimal Image-guided Frameless Stereotactic Resection
  109. Permanent Iodine-125 Interstitial Implants for the Treatment of Recurrent Glioblastoma Multiforme
  110. Clonal Origin of Recurrent Meningiomas
  111. A Syngeneic Mouse Glioma Model for Study of Glioblastoma Therapy
  112. Functional outcome of inpatient rehabilitation in persons with brain tumors
  113. A simple, reproducible technique for establishing leptomeningeal tumors in nude rats
  114. Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors
  115. Radiation Therapy and Hydroxyurea Followed by the Combination of 6-Thioguanine and BCNU for the Treatment of Primary Malignant Brain Tumors
  116. Corpus Callosal Changes Associated with Hydrocephalus: A Report of Two Cases
  117. A Novel Multiply-Mutated HSV-1 Strain for the Treatment of Human Brain Tumors
  118. Stereotactic radiosurgery for the treatment of brain metastases
  119. Intravenous Carboplatin for Recurrent Gliomas
  120. Role of genomic instability in meningioma progression
  121. Role of genomic instability in meningioma progression
  122. Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy
  123. A Method to Reduce Systematic Spatial Shift Associated with Magnetic Resonance Imaging
  124. Expression of N-cadherin and α-catenin in astrocytomas and glioblastomas
  125. Medulloblastoma in adults
  126. Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity
  127. Identification and partial sequence of a cDNA that is differentially expressed in human brain tumors
  128. RNA expression of complement regulatory proteins in human brain tumors
  129. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas
  130. In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy
  131. Intracranial myxopapillary ependymoma: Case report
  132. Intradural chordoma of the tentorium cerebelli
  133. In Vivo Metabolism of Radiolabeled Putrescine in Gliomas: Implications for Positron Emission Tomography of Brain Tumors